In people with systemic sclerosis, the gastrointestinal tract is often affected, leading to a variety of clinical presentations such as heartburn, bloating and abdominal pain. However, these symptoms can be difficult to predict due to a lack of an objective biomarker. A recent study from rheumatologist Zsuzsanna McMahan may provide some answers: She identified a relationship between anti-vinculin antibodies and gastrointestinal symptoms. McMahan shares more about her results in advance of a poster presentation at the American College of Rheumatology 2022 annual conference.

Read the abstract: acrabstracts.org/abstract/anti-vinculin-antibodies…